Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
The potential role of activin and follistatin in lung transplant dysfunction
James N Snell1,2, Glen P Westall1, Gregory I Snell1
1a Lung Transplant Service , Alfred Hospital and Monash University , Melbourne , Australia.
Abstract:
Activin A, a member of the transforming growth factor β super-family, is a key regulator of multiple biological pathways including the physiological processes of organ development and homeostasis; as well as the pathological processes of inflammation, remodelling and fibrosis. Dysregulation of activin A and its naturally occurring antagonist follistatin, contribute to the development of disease in multiple organ systems. In this review, we summarize the regulation of activin A, its dysregulated expression in a number of respiratory diseases and postulate its potential role in contributing to allograft dysfunction following lung transplantation.
Insights
Activin A regulates organ development and disease. Its dysregulation, along with follistatin, contributes to respiratory diseases and may impair lung transplant outcomes.
Area of Science:
- Biochemistry
- Immunology
- Pulmonary Medicine
Background:
- Activin A, a TGF-β superfamily member, controls organ development, homeostasis, inflammation, and fibrosis.
- Dysregulation of Activin A and its antagonist, follistatin, are implicated in various organ system diseases.
Purpose of the Study:
- To review Activin A regulation and its role in respiratory diseases.
- To explore Activin A's potential contribution to lung transplant allograft dysfunction.
Main Methods:
- Literature review on Activin A.
- Analysis of Activin A expression in respiratory diseases.
- Postulation of Activin A's role in allograft dysfunction.
Main Results:
- Activin A is a critical regulator of physiological and pathological processes.
- Altered Activin A expression is observed in several respiratory conditions.
- Activin A may play a role in the immune response post-lung transplantation.
Conclusions:
- Activin A's complex role in health and disease warrants further investigation.
- Understanding Activin A dysregulation could lead to new therapeutic strategies for respiratory diseases.
- Targeting Activin A may improve outcomes for lung transplant recipients.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

